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The classical pregnancy and tumor marker hCG has long been considered to be only accidentally expressed ectopically, e.g. by tumors. The 
biolo&al functions of low levels of hCG/3, hCGa and holo-hCG in the sera of nonpregnant healthy individuals remained unclear. Immunological 
analyses by our ultrasensitive time-resolved fluoroimmunoassays revealed a concentration gradient from < 5 pg hCGj?/ml in cubital vein serum versus 
up to 480 pg hCGj?/ml in the corresponding beni testicular hydrocele fluids. Moreover, hCGb and its cognate molecule luteinizing hormone/? (LHB) 
were present in cytosolic extracts of normal human testes. Both hCGj? and hLH#I are eutopically produced as proven by RT-l?CR and subsequent 
Southern and dot blot analyses. Thus, the view of a purely systemic hormonal function of hLH, and of hCG during pregnancy needs a reassessement 
as hCG@ and hLIQ3 are synthesized in the human testis and autocrine/paracrine actions seem to be likely. 
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1. fruition 
Physiologically, the most important pregnancy 
marker human chorionic gonadotropin (hCG) is consid- 
ered to act systemically as a hormone on the human 
ovary in order to sustain progesterone secretion. In addi- 
tion to its synthesis in the placenta, hCG is produced by 
a variety of both trophoblastic and nontrophoblastic 
malignancies and serves as a well established tumor 
marker for testicular cancer [l-3]. Moreover, hCG and 
its free a (hCGa) and /S-subunits (hCG/j) have been dem- 
onstrated in various body fluids such as serum, urine and 
hydrocele fluid in normal healthy female and male popu- 
lations [1,2,4], with levels correlated to age [5]. The pitu- 
itary which is the site of production for LH has been 
considered to be the main source of these ectopically 
synthesized hCG-derived molecules [6]. 
HCGB is encoded by six genes linked physically to a 
single highly homologous gene for luteinizing hormone 
p-subunit (LHj?) all of which are arranged in a single 
cluster on chromosome 19 [7]. The six members of the 
hCGB gene family are essentially transcriptionally active 
in the placenta and the choriocarcinoma cell line JAr [8]. 
More than a decade ago reports appeared that hCG-like 
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substances are widespread in other normal tissues in- 
cluding normal testis (for review see [9]). After the advent 
of monoclonal antibodies and the introduction of two- 
site monoclonal antibody based immunoassays only few 
of these data could be verified [1,6]. The biological func- 
tion of ectopically produced hCG which could be 
detected in minute concentrations in serum remained 
unclear. As there is increasing evidence for the impor- 
tance of local operative autocrine/paracrine mechanisms 
in reproductive organs such as the testis [l&l 31 and as 
we previously demonstrated that irrespective of histol- 
ogy all testicular cancers secrete hCG-like molecules, we 
hypothesized that in addition to pituitary derived LH, 
which is definitely the primary support for Leydig cell 
function, locally produced LH- and hCG-derived mole- 
cules in the normal human testis might act as autocrine 
or paracrine modulators of testicular physiology. 
2. Materials and methods 
2.1. Tissues, eelis and body @ids 
Testes from 19 men undergoing orchiectomy for previously untreated 
prostatic cancer and a post mortem male pituitary (29 a) were snap 
frozen in liquid nitrogen and kept at -70” until used. 
For immunological determinations of hCG- or LH-derived mole- 
cules one gram of each decapsulated testis was homogenized in 5 ml 
ice-cold phosphate-buffered saline (PBS, pH 7.2) with an Ultra turrax 
tissue homogenizer (5 x 20 s), followed by centrifugation at 19,000 x g 
for 20 min (4*C). The supernatant was stored at -20°C until tested. 
Serum and hydrocele fluids were obtained from 11 patients undergoing 
All rights reserved. 
230 I? Berger et al. IFEBS Letters 343 (1994) 229-233 
hydrocele operations for benign reasons and stored frozen. All the 
patients gave informed consent. 
2.2. Tme-resolvedjfuoroimmunoassays (IFMA) 
Immunological determinations of holo-hCG, free hCGp, free hCGcr 
and hLm were performed by highly specific and sensitive (2 pg/ml) 
time-resolved IFMAs [1,5,14] based on our monoclonal antibodies 
(MCA) against hCG, free hCGa and free hCGjI which have been 
produced and characterized as described elsewhere [15-171. MCA (code 
19/l) directed against hLw were produced by Dr. Siddle [18]. 
2.3. Isolation of total RNA 
Total RNA was extracted either from one gram of testis, term preg- 
nancy human placenta, pituitary or from 2 x lo6 BeWo chorio- 
carcinoma cells and human thyroid epithelial cells by the single step 
acid guanidium thiocyanate phenohchloroform ethod of Chomxynski 
and Sac&i [19]. Extreme care was taken to avoid specimen contamina- 
tion during the extraction procedure including using filtered pipet tips 
and sterile containers. The integrity of RNA was assessed by analysis 
of 28s and 18s rRNA on ethidium bromide-stained 1% agarose gels 
(Boehringer-Mannheim, Mannheim, Germany). 
2.4. Reverse transcription 
Between 300-500 ng of total RNA were diluted in 5 ~1 DEPC water 
in a 0.5 ml PCR tube (Perkin-Elmer Cetus, Norwalk, CT), denaturated 
at 75°C for 3 min in a programmable thermal cycler (I’C; Techne, 
Cambridge, UK), then rapidly cooled to 4°C and the reverse transcrip- 
tion performed in a final volume of 40 pl under the following reaction 
conditions: 50 mM Tris-HCl (pH 8.3), 50 mM KCl, 10 mM MgCl,, 
0.5 mM spermidine, 10 mM dithiothreitol, 1 mM each of deoxy-ATP 
(dATP), dCTP, dGTP and d’lTP (Promega, Madison, WI, USA), 
40 U human placental ribonuclease inhibitor (Promega), 200 pmol 
random hexamer oligonucleotide (Boehringer-Mannheim, Germany) 
and 10 U avian myeloblastosis virus reverse transcriptase (Promega). 
The reaction mix was incubated for 8 min at 20°C and 8 min at 25” C 
to allow hybridization between the RNA and the hexamer primers. The 
reverse transcription was then allowed to proceed at 42°C for 30 min. 
This cycle was repeated four times to increase the amount of cDNA. 
2.5. PCR 
For PCR amplification [20],5 ~1 of each first strand reaction contain- 
ing the cDNA was placedin a sterile 0.5 ml PCR tube in a final volume 
of 25 ul with the followine reaction conditions: 10 mM Tris-HCl 
(pH 9), 50 mM KCl, 1.5 mMMgCl,, 0.1% Triton X-l 00,0.2 mM each 
of deoxy-ATP (dATP), dCTP, dGTP and dlTP, 4 pmol each of the two 
oligonucleotide primers specific for hCG/J gene products and 1 U Taq 
polymerase (Perk&Elmer Cetus) at pH 9. After an initial denaturation 
for 3 min at 94”C, 35 cycles of amplification were performed with 1 min 
denaturation at 95°C 1 min annealing at 55”C, and 2 min extension 
at 73°C in a TC. The last cycle had an elongation time of 5 rnin 
at 73C. 
Three sets of primer pairs either specific for the hCG/S genes 1 and 
2 (5’-CCCCAGTGCTTGCGGAAGATA-3’ located at hCG@DNA 
-801-60 and 5’-CCGGCAGGACCCCCTGCAGCA-3’ at position 
191/211X or hCGB genes 3,5,7 and 8 (S-TCGGGTCACGGCCTCCT- 
3’ located at -3511-335 and 5’-TCGGGGTGTCCGAGGGC-3’ at 
468/484) [8] or the hLH@ gene (5’-ACCGTCAACACCACCATCT-3 
located at 142061 and 5’-AGAGCCACAGGGAAGGAGAC-3’ at 
299/318), were custom-made by Microsynth (Windisch, Switzerland). 
2.6. Gel electrophoresis and Southern blot analysis 
PCR products were electrophoresed on 2% agarose gels, stained with 
ethidium bromide and photographed under UV light. Amplified cDNA 
was then transferred by capillary transfer to a nylon membrane filter 
(Bio-Rad Laboratories; Richmond, CA, USA), crosslinked by using an 
UV crosslinker (Stratagene, La Jolla, CA, USA) and, after prehybridi- 
ration [21], hybridized (37”C, overnight) with a synthetic 18-oligo 
nucleotide complementary to cDNA nucleotides 126143 (5’- 
CTGCCCCGTGTGCATCAC-3’) in exon 2 of the hCG/I genes. This 
probe was radioactively labeled to a specific activity of 3.x 10” cpm/ml 
usina Ir-‘*PlATP CNEN Research Products. Boston, MA, USA) and 
I _. 
T4 polynucieotide‘kinase Qromega). Filters’ were washed twice for 15 
min each at room temperature and 58°C with 300 mM NaCY30 mM 
sodiumcitrate/O. 1% sodiumdodecyl sulfate (SDS) and then exposed to 
Agfa RP-1 film (Agfa, Vienna, Austria) at -7O’C for 3 h. 
2.7. Dot blot analysis 
HLW (177 bp) and hCG/J 3,5,7 and 8 (835 bp) -PCR products were 
purified using Wmard PCR Preps (Promega), ethanol precipitated, dot- 
ted onto nylon membranes, denatured [21] and processed as described 
for Southern blot analysis (hybridization at 42’C). 3zP-labeled oligonu- 
cleotides were complementary to cDNA nucleotides 178-194 specific 
either for hCGB (5’-ACCATGACCCGCGTGCT-31 or for hLHfJ (S- 
ACCATGATGCGCGTGCT-3’). The specific washing steps were per- 
formed twice for 3 min at 60°C (hLH/3 probe) or at 61°C (hCG/J probe). 
3. Results 
3.1. hCG, hCGa and hCGP in serum, hydrocele _&id 
and testicular extract 
In hydrocele fluids hCG was present only in a single 
case and free hCGcl in 5111 (mean, 75 pg/ml; range, 
O-620 pg/ml). Corresponding serum levels were within 
the normal range (hCG: < 7pg/ml; hCGa < 196 pg/ml) 
as defined previously [5]. A clear-cut concentration gra- 
dient of hCG/I could be observed from serum (< 5 pg./ml, 
all samples) to hydrocele fluids which were positive in 
10/l 1 samples (mean, 226 pg/ml; range, O-480 pg/ml). In 
addition, all cytosolic testicular extracts contained free 
hCGB (mean, 12.4 rig/g; range, 2-22.8 nglg, tissue wet 
weight) and hLm (mean, 0.9 rig/g;; range, 0.07-3.3 nglg). 
3.2. Expression ofhC@ and hLm genes in human testis 
Proof for the eutopic testicular production of hLI-I/? 
and hCG/I gene derived molecules has been achived by 
RT-PCR and consecutive Southern hybridization or dot 
blot analyses. Both primer pairs specific for products of 
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Fig. 1. Detection of mRNA from hCG/J genes 3, 5, 7 and 8 in human 
testes by RT-PCR. Five different testes had a positive signal at the 
predicted size of 835 bp. The cDNA obtained from both human pla- 
centa and BeWo choriocarcinoma cells served as a positive control and 
cDNA derived from human thyroid epithelial cells as a negative con- 
trol. Amplification of genomic hCG/J DNA (internal control) resulted 
in the expected 1420 bp fragment. (A) shows the ethidium-bromide 
stained agarose gel (2%), and (B) the verification of the hCGj RT-PCR 
product by Southern hybridization with a [‘*P]hCGjJ 18 bp oligonucle- 
otide (position 126143) which was different from both PCR primers. 
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Fig. 2. Detection of hCGB gene l&2 mRNA in human testes by RT- 
PCR. Amplified testicular cDNA generated three transcripts (410,420 
and 244 bp) arising from alternative splicing sites as tirst described by 
Bo and Boime [8] for placental tissue. Testicular RNA preparations 
where reverse transcriptase was omitted from the reaction mixture 
(testis-RT) contained no cDNA templates. The predicted and observed 
sire of PCR-amplified genomic DNA was 876 bp (internal control). SM, 
size marker. Panel A shows the ethidium-bromide stained hCGfi gene 
1 and 2 RT-PCR products separated with a 2% agarose gel, and panel 
B the verification of product specificity by Southern hybridization with 
a [‘rP]hCG/3 oligonucleotide (position 126-143) as in Fig. 1B. 
hCGB genes 3, 5, 7 and 8 (835) and hCG/? genes 1 and 
2 (244, 410, 420 bp), respectively, yielded fragments of 
the predicted lengths (Figs. 1A and 2A). It appeared that 
the testicular hCG/i cDNAs are heterogeneous in nature 
and include the three alternative splicing products of 
hCG/3 genes 1 and 2 originally described for the placenta 
[8]. The same results were obtained for the chorion- 
carcinoma cell line BeWo and term pregnancy placenta 
which were run in parallel. The hLm primer pair gener- 
ated an expected fragment of 177 bp (Fig. 3). The frag- 
ments were not amplified from genomic DNA as other- 
wise due to intron sequences bands of 1420 bp for hCG/I 
genes 3, 5,7 and 8 and 876 bp for hCGJ3 genes 1 and 2, 
respectively, and 410 bp for hLH/I would have been 
generated. HLI-I/? cDNA was not amplified by the two 
hCG/I specific primer pairs due to its much shorter 5’- 
untranslated region. Southern transfer of the hCG/I RT- 
PCR products and hybridization with a different hCG/I 
probe (position 126-143) (Figs. 1B and 2B) and dot blot 
analyses of hLw-products with specific hLw and 
hCG/I probes (Fig. 4) validated the speci&y of the PCR 
products. Additional proof of LH@- and hCG/&product 
specificity was obtained by digestions with the restriction 
enzymes HaeIII (Boehringer Mannheim) and ApaL 
(USB, Cleveland, OH) (data not shown). 
4. Discussion 
HCG is a glycoprotein hormone which is eutopically 
expressed at high levels by trophoblastic cells of the pla- 
centa starting at the 6- to 8-cell stage of the blastocyst 
(for review see [22]). Its classical physiological role is to 
sustain progesterone secretion by the corpus luteum to 
maintain pregnancy. Ectopic secretion by a variety of 
nontrophoblastic tumors made hCG and its free subunits 
hCGa and hCG/3 useful biochemical markers for malig- 
nancy [1,2,4]. So far the only biological function of ec- 
topically secreted hCG-like molecules could be ascribed 
to free hCGcl as to be critical for certain transformation 
phenotypes of human lung tumor cells (ChaGo) [23]. As 
early as in the 70ies hCG production could be shown in 
normal tissues (for review see [9,24,25]). However, this 
remained a highly controversial issue as, except for the 
pituitary where hCG/I gene expression has been demon- 
strated by cloning a hCG/!? cDNA [26], proof for struc- 
tural identity between these immunoreactive hCG-like 
substances and genuine hCG was still lacking. Thus, the 
pituitary was considered to be the major source of hCG- 
derived molecules present in minute concentrations in 
body fluids [l/l-6]. 
Investigating hCG, hCGa and hCG/I secretion pat- 
terns of testicular tumor cells in vivo it appeared that 
hCG-derivatives were secreted irrespective of histology. 
In the present study we found a significantly increasing 
concentration gradient of free hCGB from serum to be- 
nign testicular hydrocele fluids. Although free hCG/I and 
hLI-@ could be demonstrated by time resolved fluoroim- 
hLHA 410 bp 
+ gen. DNA 
hLHB177 bp 
*cDNA 
Fig. 3. Amplification of hLH/l cDNA by RT-PCR using the primers 
described in material and methods. The cDNAs of two different human 
testes, pituitary derived cDNA and the BeWo choriocarcinoma cDNA 
yielded a PCR-fragment at the calculated size of 177 bp visualized by 
ethidium bromide staining after electrophoresis n 2% agarose. Human 
thyroid epithelial cells served as a negative control. The predicted size 
of the PCR-generated genomic DNA was 410 bp. 
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Fig. 4. Dot blot analysis of the 177 bp hLH/%PCR fragment shown in 
Fig. 3. Two ~1 each of the purified PCR-products were dotted on a 
nylon membrane and hybridized with either (A) a hCGp-specitic (posi- 
tion 178-194) or (B) a hLH&ecihc (position 178-194) “P-labeled 
oligonucleotide. Clearly, human testes as well as the pituitary but not 
the choriocarcinoma cell-line BeWo express hLH/?. The positive signal 
obtained with BeWo cDNA with the hCGB-probe results from cross- 
amplification of the highly abundant, homologous hCG/l nucleotide 
sequence by the Lw-primers. 
munoassays in cytosolic testicular extracts they might 
have been produced in the periphery and accumulated 
locally by testicular LH/CG-receptors. But as proven by 
the sensitive RT-PCR technique and subsequent South- 
ern blot and Dot Blot analysis hCGp and hLI$3 are of 
genuine testicular origin and not metabolic degradation 
products of the Leydig cell. 
Apart from the primary hypophyseal support of Ser- 
toli and Leydig cell function by follicle stimulating 
hormone (FSH) and hLH there is increasing evidence 
that testicular cell-cell interactions are of major impor- 
tance for testicular function [l 11. In addition to testoster- 
one acting as essential paracrine factor for spermato- 
genesis a number of potential autocrine or paracrine 
regulatory substances uch as &endorphin, enkephalins, 
dynorphins, oxytocin, activin, LH releasing hormone 
(LHRH), insulin like growth factor I and other growth 
factors have been identified in the testis of various ma- 
malian species [l l-13,27]. Moreover, it is now well rec- 
ognized that originally pituitary derived hormones are 
not confined to this organ but are eutopically synthe- 
sized, e.g. in the myometrium or in activated T-lympho- 
cytes as it is the case for prolactin [28]. The same is true 
for the classical placental derived pregnancy hormone 
hCG and for the pituitary hormone LH: the physiologi- 
cal eutopic production of hCG/3 and hLI@ in the human 
testis has now been demonstrated for the first time at 
both the level of mRNA and the protein level. 
Our tindings raise two important questions: First, 
which testicular cells do hCGB and hLH@ originate from 
and second, what is the biological function of these mol- 
ecules? As testicular LHRH has been suggested to be a 
secretory product of the Sertoli cell acting on the Leydig 
cell [12] one could speculate that the latter is the site of 
hCGp and/or hLH/I production in the testis. Thus, in 
analogy to the placenta and the pituitary, hCG- or hLH- 
production could be stimulated by LHRH in order to 
sustain basal testosterone secretion. On the other hand, 
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we immunologically have picked up most likely only part 
of the hCG/I gene derived proteins as indicated by RT- 
PCR alternative splicing products which might give rise 
to entirely different protein sequences [8]. These putative 
molecules probably will not be able to assemble with 
hCGol to holo-hCG and therefore might have currently 
unknown autocrine/paracrine functions. Thus, the para- 
digms of purely systemical hormonal functions during 
pregnancy or the female cycle of eutopic placental- 
derived hCG or pituitary hLH and of accidental ectopic 
hCG production need to be reassessed. 
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